Detalles de la búsqueda
1.
Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.
Genes Dev
; 28(12): 1337-50, 2014 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24939936
2.
Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production.
Biol Reprod
; 94(3): 59, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26819475
3.
Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.
Am J Obstet Gynecol
; 214(4): 521.e1-521.e8, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26880734
4.
Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Am J Obstet Gynecol
; 214(3): 356.e1-356.e15, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26721779
5.
PAPPA2 is increased in severe early onset pre-eclampsia and upregulated with hypoxia.
Reprod Fertil Dev
; 26(2): 351-7, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23484525
6.
Corin, an enzyme with a putative role in spiral artery remodeling, is up-regulated in late secretory endometrium and first trimester decidua.
Hum Reprod
; 28(5): 1172-80, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23434834
7.
Nicotinamide and its effects on endothelial dysfunction and secretion of antiangiogenic factors by primary human placental cells and tissues.
Placenta
; 109: 28-31, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33957335
8.
Combining metformin and sulfasalazine additively reduces the secretion of antiangiogenic factors from the placenta: Implications for the treatment of preeclampsia.
Placenta
; 95: 78-83, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32452405
9.
Sulfasalazine decreases soluble fms-like tyrosine kinase-1 secretion potentially via inhibition of upstream placental epidermal growth factor receptor signalling.
Placenta
; 87: 53-57, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31561065
10.
Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.
EBioMedicine
; 41: 636-648, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30824385
11.
Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
Hypertension
; 70(5): 1014-1024, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28947613
12.
Key players of the necroptosis pathway RIPK1 and SIRT2 are altered in placenta from preeclampsia and fetal growth restriction.
Placenta
; 51: 1-9, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28292463
13.
Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia.
J Matern Fetal Neonatal Med
; 30(6): 635-639, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27124553
14.
Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction.
Hypertension
; 69(3): 457-468, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28115513
15.
Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.
Pregnancy Hypertens
; 6(2): 95-102, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27155335
16.
A wash step at collection of placental biopsies from preeclamptic pregnancies does not adversely affect levels of sFlt-1 or endoglin.
Pregnancy Hypertens
; 5(4): 294-7, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26597743
17.
YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia.
Mol Cell Endocrinol
; 413: 202-8, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26159901
18.
Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
Hypertension
; 66(5): 1073-81, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26324507
19.
Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
Hypertension
; 66(6): 1251-9, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26416849
20.
Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
Hypertension
; 65(4): 855-62, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25667213